Searched for
PHARMA IPO SUBSCRIPTION
Sudeep Pharma IPO Day 2: Subscribed over 2.5x, GMP rises. Should you apply?Sudeep Pharma’s Rs 895-crore IPO has seen strong early interest, already oversubscribed on Day 1 with robust demand from retail and NII inv...24 Nov, 2025, 11.26 AM IST- Sudeep Pharma IPO: GMP jumps 16% ahead of November 21 launch. Check tentative listing priceSudeep Pharma’s Rs 895-crore IPO is set to open on November 21, comprising a Rs 95-crore fresh issue and an Rs 800-crore OFS. The price ban...19 Nov, 2025, 02.21 PM IST
- Asston Pharma SME IPO subscribed over 173 times on final day. GMP hints at 24% listing gainsAsston Pharmaceuticals’ IPO, priced at Rs 115–123 per share, has seen strong investor interest, with a GMP of Rs 30 ahead of its July 16 BS...11 Jul, 2025, 05.17 PM IST
- Senores Pharma IPO subscribed 93.41 times on Day 3. Check GMP, listing date and other key detailsSenores Pharma's IPO subscription was oversubscribed at 93.41 times driven by retail, non-institutional, and qualified institutional buyers...24 Dec, 2024, 07.35 PM IST
- Senores Pharma IPO subscribed 13.88 times on Day 2. Check GMP, key dates, price bandRetail investors subscribed to the issue 38.34 times, while non-institutional investors (NIIs) subscribed 24.48 times. Qualified institutio...23 Dec, 2024, 06.46 PM IST
- Senores Pharma IPO subscribed 1.8 times on Day 1: Check key dates, price band, GMP and reviewSenores Pharmaceuticals' IPO received 1.8 times subscription on its opening day, driven primarily by retail investors, who oversubscribed b...20 Dec, 2024, 05.57 PM IST
- Akums Drugs & Pharma IPO share allotment to be finalised today: Check status, GMP, listing date and other detailsAkums Drugs & Pharma share allotment has been finalised. Shares will be out on August 6. The IPO was subscribed 63.5 times. Proceeds will a...02 Aug, 2024, 10.13 AM IST
- Pyramid Technoplast among 5 IPOs to watch out for this weekPyramid Technoplast aims to raise anywhere between Rs 139 crore - Rs 153 crore through the IPO, and the post implied market cap is likely t...13 Aug, 2023, 11.21 AM IST
- Mankind Pharma IPO subscribed 15.32 timesThis will be one of the largest public issues by a domestic drug manufacturer after the ₹6,480-crore IPO of Gland Pharma in 2020. The quali...28 Apr, 2023, 05.58 AM IST
- Mankind Pharma IPO sails through on Day 3Around nine brokerages have given "subscribe" recommendations on the issue, with some of them seeing the potential in the long term. Analys...27 Apr, 2023, 07.30 PM IST
- Mankind Pharma IPO subscribed 32% so far on Day 2. Check GMP and other details.Mankind Pharma's initial public offering (IPO), which will close on January 19, has been subscribed by 32% on Day 2 with non-institutional ...27 Apr, 2023, 09.13 AM IST
- Mankind Pharma IPO subscribed 14% on Day 1; GMP inches up at Rs 90-95The Rs 4,300-crore IPO, solely an offer for sale (OFS), will be available for public to bid till April 27. Investors can bid for 13 shares ...25 Apr, 2023, 07.17 PM IST
- Mankind Pharma IPO opens on Tuesday. What GMP suggests for potential investors?The company has fixed a price band of Rs 1,026-1,080 for its IPO, which is completely an offer for sale (OFS) of 40 million equity shares b...25 Apr, 2023, 11.28 AM IST
- Gland Pharma issue subscribed 2.06 timesGland Pharma’s initial public offer (IPO), the biggest ever offering in the Indian pharmaceutical sector — was subscribed 2.06 times on the...12 Nov, 2020, 08.21 AM IST
- Gland Pharma’s Rs 6,480 crore IPO sails through, gets 2.06x bidsProgressive Share Brokers said that sentiment towards the IPO has dampened a bit due to Chinese investments as well as from the fact that S...11 Nov, 2020, 06.28 PM IST
- Gland Pharma IPO: Issue date, price band & other key detailsThe drugmarker will likely announce the name of anchor investors by the end of Friday.06 Nov, 2020, 02.17 PM IST
- Bafna Pharma IPO opens for subscriptionThe initial public offering of Bafna Pharmaceuticals opened for subscription Tuesday. The company is offering 64,00,000 equity shares of Rs...27 May, 2008, 12.10 PM IST
Load More
